Cell-laden alginate hydrogels for the treatment of diabetes

References

• Norris JM, Johnson RK, Stene LC. Type 1 diabetes-early life origins and changing epidemiology. Lancet Diabetes Endocrinol. 2020;8(3):226–238.
   PubMed Web of Science ®Google Scholar
• Idf: diabetes facts and figures [internet]. Belgium: international Diabetes Federation; 2019. Available from: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html
   Google Scholar
• Centers for Disease Control and Prevention. National diabetes statistics report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2020.
   Google Scholar
• DL E, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol. 2020. DOI:10.1038/s41574-020-0355-7.
   Google Scholar
• Farina M, Alexander JF, Thekkedath U, et al. Cell encapsulation: overcoming barriers in cell transplantation in diabetes and beyond. Adv Drug Deliv Rev. 2019;139:92–115.
   PubMed Web of Science ®Google Scholar
• Chang TM. Semipermeable microcapsules. Science. 1964;146:524–525.
   PubMed Web of Science ®Google Scholar
• Lim F, Sun AM. Microencapsulated islets as bioartificial endocrine pancreas. Science. 1980;210:908–910.
   PubMed Web of Science ®Google Scholar
• Orive G, Emerich D, Khademhosseini A, et al., Engineering a clinically translatable bioartificial pancreas to treat type I diabetes. Trends Biotechnol. 2018;36(4): 445–456.
   PubMed Web of Science ®Google Scholar
• Memon B, Abdelalim EM. Stem cell therapy for diabetes: beta cells versus pancreatic progenitors. Cells. 2020 Jan 23;9(2):283.
   PubMed Web of Science ®Google Scholar
• Paolone G, Falcicchia C, Lovisari F, et al. Long-term, targeted delivery of GDNF from encapsulated cells is neuroprotective and reduces seizures in the pilocarpine model of epilepsy. J Neurosci. 2019;39(11):2144–2156
   PubMed Web of Science ®Google Scholar
• Ghani MW, Ye L, Yi Z, et al. Pancreatic β-cell replacement: advances in protocols used for differentiation of pancreatic progenitors to β-like cells. Folia Histochem Cytobiol. 2019;57(3):101–115
   PubMed Web of Science ®Google Scholar
• Lee J, Bayarsaikhan D, Bayarsaikhan G, et al. Recent advances in genome editing of stem cells for drug discovery and therapeutic application. Pharmacol Ther. 2020;209:107501.
   PubMed Web of Science ®Google Scholar
• Hu S, de Vos P. Polymeric approaches to reduce tissue responses against devices applied for islet-cell encapsulation. Front Bioeng Biotechnol. 2019;7:134.
   PubMed Web of Science ®Google Scholar
• Teramura Y, Iwata H. Bioartificial pancreas microencapsulation and conformal coating of islet of Langerhans. Adv Drug Deliv Rev. 2010;62(7–8):827–840
   PubMed Web of Science ®Google Scholar
• Teramura Y, Oommen OP, Olerud J, et al. Microencapsulation of cells, including islets, within stable ultra-thin membranes of maleimide-conjugated PEG-lipid with multifunctional crosslinkers. Biomaterials. 2013;34(11):2683–2693
   PubMed Web of Science ®Google Scholar
• Prochorov AV, Tretjak SI, Goranov VA, et al. Treatment of insulin dependent diabetes mellitus with intravascular transplantation of pancreatic islet cells without immunosuppressive therapy. Adv Med Sci. 2008;53(2):240–244
   PubMed Web of Science ®Google Scholar
• Song S, Blaha C, Moses W, et al. An intravascular bioartificial pancreas device (iBAP) with silicon nanopore membranes (SNM) for islet encapsulation under convective mass transport. Lab Chip. 2017;17(10):1778–1792
   PubMed Web of Science ®Google Scholar
• Hrvatin S, O’Donnell CW, Deng F, et al. Differentiated human stem cells resemble fetal, not adult, beta cells. Proc Natl Acad Sci U S A. 2014;111(8):3038–3043
   PubMed Web of Science ®Google Scholar
• Naujok O, Burns C, Jones PM, et al. Insulin-producing surrogate beta-cells from embryonic stem cells: are we there yet? Mol Ther. 2011;19(10):1759–1768
   PubMed Web of Science ®Google Scholar
• Evron Y, Colton CK, Ludwig B, et al. Long-term viability and function of transplanted islets macroencapsulated at high density are achieved by enhanced oxygen supply. Sci Rep. 2018;8(1):6508
   PubMedGoogle Scholar
• Ludwig B, Ludwig S, Steffen A, et al. Favorable outcome of experimental islet xenotransplantation without immunosuppression in a nonhuman primate model of diabetes. Proc Natl Acad Sci U S A. 2017;114(44):11745–11750
   PubMed Web of Science ®Google Scholar
• Barkai U, Weir GC, Colton CK, et al. Enhanced oxygen supply improves islet viability in a new bioartificial pancreas. Cell Transplant. 2013;22(8):1463–1476
   PubMed Web of Science ®Google Scholar
• An D, Wang LH, Ernst AU, et al., An atmosphere-breathing refillable biphasic device for cell replacement therapy. Adv Mater. 2019;31(52): e1905135
   PubMed Web of Science ®Google Scholar
• Cao R, Avgoustiniatos E, Papas K, et al. Mathematical predictions of oxygen availability in micro- and macro-encapsulated human and porcine pancreatic islets. J Biomed Mater Res B Appl Biomater. 2020;108(2):343–352
   PubMed Web of Science ®Google Scholar
• Kendall WF Jr, Opara EC. Polymeric materials for perm-selective coating of alginate microbeads. Methods Mol Biol. 2017;1479:95–109.
   PubMedGoogle Scholar
• Liu Q, Chiu A, Wang LH, et al. Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulation. Nat Commun. 2019;10(1):5262
   PubMedGoogle Scholar
• Vegas AJ, Veiseh O, Gurtler M, et al., Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med. 2016;22(3): 306–311
   PubMed Web of Science ®Google Scholar
• Spasojevic M, Vorenkamp J, Jansen M, et al. Synthesis and phase behavior of Poly(N-isopropylacrylamide)-b-Poly(L-Lysine Hydrochloride) and Poly(N-Isopropylacrylamide-co-Acrylamide)-b-Poly(L-Lysine Hydrochloride). Materials (Basel). 2014;7(7):5305–5326
   PubMed Web of Science ®Google Scholar
• Llacua LA, Hoek A, de Haan BJ, et al. Collagen type VI interaction improves human islet survival in immunoisolating microcapsules for treatment of diabetes. Islets. 2018;10(2):60–68
   PubMed Web of Science ®Google Scholar
• Bruni A, Gala-Lopez B, Pepper AR, et al. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes. 2014;7:211–223.
   PubMedGoogle Scholar
• Cooper DK, Ekser B, Ramsoondar J, et al. The role of genetically engineered pigs in xenotransplantation research. J Pathol. 2016;238(2):288–299
   PubMed Web of Science ®Google Scholar
• Dufrane D, Goebbels RM, Saliez A, et al. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation. 2006;81(9):1345–1353
   PubMed Web of Science ®Google Scholar
• Safley SA, Kenyon NS, Berman DM, et al. Microencapsulated adult porcine islets transplanted intraperitoneally in streptozotocin-diabetic non-human primates. Xenotransplantation. 2018;25(6):e12450
   PubMed Web of Science ®Google Scholar
• Matsumoto S, Abalovich A, Wechsler C, et al. Clinical benefit of islet xenotransplantation for the treatment of type 1 diabetes. EBioMedicine. 2016;12:255–262.
   PubMed Web of Science ®Google Scholar
• Hillberg AL, Oudshoorn M, Lam JB, et al. Encapsulation of porcine pancreatic islets within an immunoprotective capsule comprising methacrylated glycol chitosan and alginate. J Biomed Mater Res B Appl Biomater. 2015;103(3):503–518
   PubMed Web of Science ®Google Scholar
• Pagliuca FW, Millman JR, Gurtler M, et al. Generation of functional human pancreatic beta cells in vitro. Cell. 2014;159(2):428–439
   PubMed Web of Science ®Google Scholar